The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

USA: A target trial emulation study revealed that denosumab significantly increased the risk of hypocalcemia requiring ...

Medically reviewed by Kashif J. Piracha, MD Vitamin D deficiency is a condition in which your body does not get or process ...

This week’s episodes of The Dairy Signal are sponsored by Zinpro Corporation. For over 50 years, Zinpro has pioneered the research and development of performance trace minerals and innovative ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

Considering taking supplements to treat hypocalcemia? Below is a list of common natural remedies used to treat or reduce the symptoms of hypocalcemia. Follow the links to read common uses ...

The Food and Drug Administration (FDA) has added a new boxed warning on the denosumab drug label (brand name: Prolia) to alert clinicians to an increased risk for severe hypocalcemia in patients with ...

Calcitonin-salmon 200 IU/mL; soln for SC or IM inj. Correct hypocalcemia and other mineral metabolism disorders before initiating; monitor serum calcium and hypocalcemia symptoms during therapy.

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

The researchers found that with denosumab vs oral bisphosphonates, the risk for emergently treated hypocalcemia increased with worsening CKD stage. (HealthDay News) — For patients with chronic ...